Company performance
Add to research
Current Price
as of Feb 07, 2025$14.09
P/E Ratio
N/A
Market Cap
$640.67M
Description
Add to research
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCAPR
- Price$14.09-1.67%
Trading Information
- Market cap$640.67M
- Float87.92%
- Average Daily Volume (1m)714,623
- Average Daily Volume (3m)1,189,226
- EPS-$1.06
Company
- Revenue$23.23M
- Rev growth (1yr)-63.44%
- Net income-$12.56M
- Gross margin84.03%
- EBITDA margin-559.27%
- EBITDA-$12.65M
- EV$423.30M
- EV/Revenue18.22
- P/EN/A
- P/S20.07
- P/B8.32
- Debt/Equity7.36
Documents
Add to research
SEC Filings
Factset Street Account